We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.53B
1-Year Est. Return 154.61%
This Fund
S&P 500
This Quarter Est. Return
+33.46%
1 Year Est. Return
+154.61%
3 Year Est. Return
+564.07%
5 Year Est. Return
+985.88%
10 Year Est. Return
–
AUM
$2.53B
AUM Growth
+$441M
Cap. Flow
+$174M
Cap. Flow %
6.85%
Top 10 Hldgs %
44.81%
Holding
120
New
30
Increased
23
Reduced
22
Closed
28

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$84.8M
2
AXSM icon
Axsome Therapeutics
AXSM
+$57.5M
3
EW icon
Edwards Lifesciences
EW
+$38.1M
4
ABT icon
Abbott
ABT
+$36.5M
5
UNH icon
UnitedHealth
UNH
+$31.5M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$49.3M
2
BTSG icon
BrightSpring Health Services
BTSG
+$38.9M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$30.6M
4
CNC icon
Centene
CNC
+$18.7M
5
FMS icon
Fresenius Medical Care
FMS
+$17.5M

Sector Composition

Rank Sector Weight
1 Healthcare 96.27%
2 Miscellaneous 3.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$43.9B
$281M 11.1%
1,500,000
– –
INSM icon
2
Insmed
INSM
$25.7B
$171M 6.74%
1,600,000
+100,000
+7% +$12.1M
CYTK icon
3
Cytokinetics
CYTK
$8.99B
$136M 5.38%
1,600,000
– –
CVS icon
4
CVS Health
CVS
$114B
$114M 4.49%
1,100,000
+950,000
+633% +$84.8M
EWTX icon
5
Edgewise Therapeutics
EWTX
$4.27B
$81.3M 3.21%
2,000,000
+400,000
+25% +$13.8M
VERA icon
6
Vera Therapeutics
VERA
$2.34B
$75.1M 2.97%
1,750,000
+150,000
+9% +$5.59M
AXSM icon
7
Axsome Therapeutics
AXSM
$10.2B
$73.4M 2.9%
300,000
+265,000
+757% +$57.5M
CAH icon
8
Cardinal Health
CAH
$51B
$71.3M 2.82%
300,000
+30,000
+11% +$6.23M
ROIV icon
9
Roivant Sciences
ROIV
$25.9B
$70.8M 2.8%
2,000,000
– –
RYTM icon
10
Rhythm Pharmaceuticals
RYTM
$6.79B
$61.1M 2.41%
550,000
-50,000
-8% -$4.52M
EW icon
11
Edwards Lifesciences
EW
$49.7B
$56.5M 2.23%
625,000
+455,000
+268% +$38.1M
RVMD icon
12
PUT
Revolution Medicines
RVMD
$43.9B
$56.2M 2.22%
300,000
-450,000
-60% -$65.7M
ALHC icon
13
Alignment Healthcare
ALHC
$1.7B
$47.6M 1.88%
2,000,000
-575,000
-22% -$11M
MRK icon
14
Merck
MRK
$367B
$45M 1.78%
350,000
-75,000
-18% -$8.78M
DGX icon
15
Quest Diagnostics
DGX
$26.1B
$42.4M 1.67%
200,000
+140,000
+233% +$27.5M
QURE icon
16
uniQure
QURE
$2.65B
$41.5M 1.64%
900,000
– –
SRRK icon
17
Scholar Rock
SRRK
$5.92B
$41.3M 1.63%
750,000
+250,000
+50% +$12.1M
BSX icon
18
Boston Scientific
BSX
$63.7B
$38.4M 1.52%
900,000
+350,000
+64% +$19M
BTSG icon
19
BrightSpring Health Services
BTSG
$11.2B
$38.4M 1.52%
550,000
-700,000
-56% -$38.9M
ABT icon
20
Abbott
ABT
$175B
$36.3M 1.43%
+400,000
New +$36.5M
UNH icon
21
UnitedHealth
UNH
$338B
$35.3M 1.4%
+85,000
New +$31.5M
LFST icon
22
Lifestance Health
LFST
$4.5B
$32.1M 1.27%
3,000,000
-1,300,000
-30% -$10M
NVS icon
23
Novartis
NVS
$276B
$31.3M 1.24%
200,000
-50,000
-20% -$7.5M
TNGX icon
24
Tango Therapeutics
TNGX
$4.2B
$31.3M 1.23%
1,000,000
+550,000
+122% +$13.6M
THC icon
25
Tenet Healthcare
THC
$20.9B
$30.9M 1.22%
+165,000
New +$30.3M
1
2 3 4 5

Similar funds

VWA
Visionary Wealth Advisors O'fallon, Illinois $2.53B AUM 24.4% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return
AIM
Acropolis Investment Management St. Louis, Missouri $2.54B AUM 18.96% 1-Year Est. Return
QT
Quantbot Technologies New York $2.54B AUM 22.25% 1-Year Est. Return
LMIM
Lockheed Martin Investment Management Bethesda, Maryland $2.53B AUM 37.62% 1-Year Est. Return
ST
Sageworth Trust Lancaster, Pennsylvania $2.54B AUM 23.56% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.54B AUM 17.62% 1-Year Est. Return
IFA
Index Fund Advisors Irvine, California $2.52B AUM 26.26% 1-Year Est. Return

Integral Health Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, Integral Health Asset Management held 120 positions worth $2.53B, up 21% from $2.09B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Integral Health Asset Management deployed $174M of net new capital in Q2 2026, opening 30 new positions and adding to 23 existing holdings. Its largest new stake was Abbott: 400,000 shares worth $36.3M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 90% a quarter earlier, followed by Miscellaneous.

On the sell side, the largest reduction was BrightSpring Health Services, an estimated $38.9M trimmed.

  • Integral Health Asset Management's largest Q2 2026 buy was Abbott: 400,000 shares worth $36.3M.
  • Integral Health Asset Management added most to CVS Health in Q2 2026, an estimated $84.8M increase.
  • Integral Health Asset Management's biggest Q2 2026 reduction was BrightSpring Health Services, cutting an estimated $38.9M.
  • Integral Health Asset Management fully exited AstraZeneca in Q2 2026, selling an estimated $49.3M.
  • Integral Health Asset Management's ten largest holdings make up 45% of its $2.53B portfolio in Q2 2026.
  • Integral Health Asset Management opened 30 new positions and closed 28 in Q2 2026.
  • Integral Health Asset Management's portfolio value rose 21% quarter-over-quarter to $2.53B.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.